Skip to main content
Agilent10-Q: Acquisition announced

Agilent enters definitive agreement to acquire Biocare for approximately $950 million in cash

Source: Autobound Signal API · 103 signals tracked for Agilent · updated

Get Agilent's live signals in Claude or ChatGPT, or by API

AskWhat changed at Agilent this week? Use Autobound signals for agilent.com.

What happened

On March 6, 2026, Agilent agreed to acquire 100 percent of BC Midco I, Inc. (Biocare) for approximately $950 million in cash to be integrated into its Life Sciences and Diagnostics Markets segment.

Source

SEC EDGARJun 1, 2026

Quarterly report (Form 10-Q)

Agilent 10-Q for Quarter ended Apr 30, 2026

Filing excerpt

On March 6, 2026, we entered into a definitive agreement to acquire 100 percent of the outstanding capital stock of BC Midco I, Inc. (“Biocare”) for an aggregate purchase price of approximately $950 million in cash.

sec.gov/Archives/edgar/data/1090872/000109087226000055/a-20260430.htmRead the full source

Other signals in this filing (3)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Acquisition announced

What this signalsIntegration work after a deal often opens needs for new systems and services.

Period
Quarter ended Apr 30, 2026
Fiscal year end
04/30
Filed
Jun 1, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$950M (aggregate purchase price in cash to acquire Biocare)
Percentoutstanding capital stock acquired
1%

Details

CIK
1090872
Accession number
0001090872-26-000055
Timeframe
Current year
Quarter
Q2
Filing year
2026
Period end date
Apr 30, 2026
Why it matters
Integration needs coming
Signal category
Strategic

Extraction

Confidence
High
Relevance
85%
Sentiment
Positive
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
acquisitionAnnounced

Use this data

Get every 10-Q signal for Agilent and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Agilent this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/83ced9c7-b872-4060-ac74-9f7bc17a5c31 returns this record as JSON. POST /v1/companies/enrich returns every signal for agilent.com.

{
  "signal_id": "83ced9c7-b872-4060-ac74-9f7bc17a5c31",
  "signal_type": "sec-10q",
  "signal_subtype": "acquisitionAnnounced",
  "detected_at": "2026-11-09T06:28:42.771+00:00",
  "company": {
    "name": "Agilent",
    "domain": "agilent.com"
  },
  "data": {
    "detail": "On March 6, 2026, Agilent agreed to acquire 100 percent of BC Midco I, Inc. (Biocare) for approximately $950 million in cash to be integrated into its Life Sciences and Diagnostics Markets segment. Post-close integration may create vendor opportunities for systems alignment, regulatory compliance, and workflow optimization.",
    "metrics": {
      "pct": 1,
      "timeframe": "current_year",
      "pct_context": "outstanding capital stock acquired",
      "dollar_context": "aggregate purchase price in cash to acquire Biocare",
      "dollar_millions": 950
    },
    "quarter": "Q2",
    "summary": "Agilent enters definitive agreement to acquire Biocare for approximately $950 million in cash",
    "excerpts": "On March 6, 2026, we entered into a definitive agreement to acquire 100 percent of the outstanding capital stock of BC Midco I, Inc. (“Biocare”) for an aggregate purchase price of approximately $950 million in cash.",
    "relevance": 0.85,
    "sentiment": "positive",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1090872/000109087226000055/a-20260430.htm",
    "filing_date": "2026-06-01",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "04/30",
    "period_end_date": "2026-04-30",
    "sales_relevance": "Integration needs coming",
    "signal_category": "strategic"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.